{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:10:40Z","timestamp":1791331840820,"version":"4.3.1"},"reference-count":53,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/4-5\/3\/9\/DHR\/Neuro\/2021-NCD-1"],"award-info":[{"award-number":["5\/4-5\/3\/9\/DHR\/Neuro\/2021-NCD-1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["OLP-017"],"award-info":[{"award-number":["OLP-017"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Council of Scientific &amp; Industrial Research","award":["5\/4-5\/3\/9\/DHR\/Neuro\/2021-NCD-1"],"award-info":[{"award-number":["5\/4-5\/3\/9\/DHR\/Neuro\/2021-NCD-1"]}]},{"name":"Council of Scientific &amp; Industrial Research","award":["OLP-017"],"award-info":[{"award-number":["OLP-017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background\/Objectives: TDP-43 mutation-driven Amyotrophic Lateral Sclerosis (ALS) motor neuron disease is one of the most prominent forms (approximately 97%) in cases of sporadic ALS. Dysfunctional autophagy and lysosomal function are the prime mechanisms behind ALS. Mitoxantrone (Mito), a synthetic doxorubicin analog, is an inhibitor of DNA and RNA synthesis\/repair via intercalating with nitrogenous bases and inhibiting topoisomerase II. The therapeutic potential of miRNAs associated with disease conditions has also been reported. This study explores the therapeutic potential of Mito along with miRNAs against mutated TDP-43 protein-induced proteinopathy in human-induced pluripotent stem cell (hiPSC)-derived human neural progenitor cells (hNPCs). Methods: HiPSCs mutated for TDP-43 were differentiated into hNPCs and used to explore the therapeutic potential of Mito at a concentration of 1 \u03bcM for 24 h (the identified non-cytotoxic dose). The therapeutic effects of Mito on miRNA expression and various cellular parameters such as mitochondrial dynamics, autophagy, and stress granules were assessed using the high-throughput Open Array technique, immunocytochemistry, flow cytometry, immunoblotting, and mitochondrial bioenergetic assay. Results: Mutated TDP-43 protein accumulation causes stress granule formation (G3BP1), mitochondrial bioenergetic dysfunction, SOD1 accumulation, hyperactivated autophagy, and ER stress in hNPCs. The mutated hNPCs also show dysregulation in six miRNAs (miR-543, miR-34a, miR-200c, miR-22, miR-29b, and miR-29c) in mutated hNPCs. A significant restoration of TDP-43 mutation-induced alterations could be witnessed upon the exposure of mutated hNPCs to Mito. Conclusions: Our study indicates that miR-543, miR-29b, miR-22, miR-200c, and miR-34a have antisense therapeutic potential alone and in combination with Mitoxantrone.<\/jats:p>","DOI":"10.3390\/pharmaceutics17040410","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T05:35:03Z","timestamp":1742880903000},"page":"410","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting TDP-43 Proteinopathy in hiPSC-Derived Mutated hNPCs with Mitoxantrone Drugs and miRNAs"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6760-224X","authenticated-orcid":false,"given":"Uzair A.","family":"Ansari","sequence":"first","affiliation":[{"name":"Systems Toxicology Group, FEST Division, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-2694","authenticated-orcid":false,"given":"Ankita","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Systems Toxicology Group, FEST Division, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6315-1223","authenticated-orcid":false,"given":"Ankur K.","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Systems Toxicology Group, FEST Division, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7624-4197","authenticated-orcid":false,"given":"Abhishek","family":"Pandeya","sequence":"additional","affiliation":[{"name":"Systems Toxicology Group, FEST Division, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-0394","authenticated-orcid":false,"given":"Pankhi","family":"Vatsa","sequence":"additional","affiliation":[{"name":"Systems Toxicology Group, FEST Division, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7552-5106","authenticated-orcid":false,"given":"Renu","family":"Negi","sequence":"additional","affiliation":[{"name":"Systems Toxicology Group, FEST Division, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2476-7192","authenticated-orcid":false,"given":"Akash","family":"Singh","sequence":"additional","affiliation":[{"name":"Systems Toxicology Group, FEST Division, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9178-8184","authenticated-orcid":false,"given":"Aditya B.","family":"Pant","sequence":"additional","affiliation":[{"name":"Systems Toxicology Group, FEST Division, CSIR-Indian Institute of Toxicology Research, Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India"},{"name":"Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00018-024-05164-9","article-title":"Molecular hallmarks of ageing in amyotrophic lateral sclerosis","volume":"81","author":"Jagaraj","year":"2024","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.1212\/WNL.0000000000207474","article-title":"Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis: A Systematic Review","volume":"101","author":"Wolfson","year":"2023","journal-title":"Neurology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"eadf6895","DOI":"10.1126\/sciadv.adf6895","article-title":"Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis","volume":"9","author":"Oiwa","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Dudman, J., and Qi, X. (2020). Stress Granule Dysregulation in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.598517"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: A clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.15252\/embj.201490493","article-title":"Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: A new mechanism for ALS","volume":"34","author":"Emde","year":"2015","journal-title":"EMBO J."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Paez-Colasante, X., Figueroa-Romero, C., Rumora, A.E., Hur, J., Mendelson, F.E., Hayes, J.M., Backus, C., Taubman, G.F., Heinicke, L., and Walter, N.G. (2020). Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.00117"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ryoo, H., Kimmel, H., Rondo, E., and Underhill, G.H. (2024). Advances in high throughput cell culture technologies for therapeutic screening and biological discovery applications. Bioeng. Transl. Med., 9.","DOI":"10.1002\/btm2.10627"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bombieri, C., Corsi, A., Trabetti, E., Ruggiero, A., Marchetto, G., Vattemi, G., Valenti, M.T., Zipeto, D., and Romanelli, M.G. (2024). Advanced Cellular Models for Rare Disease Study: Exploring Neural, Muscle and Skeletal Organoids. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021014"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1007\/s12035-020-02006-0","article-title":"Mechanistic Insights of Astrocyte-Mediated Hyperactive Autophagy and Loss of Motor Neuron Function in SOD1(L39R) Linked Amyotrophic Lateral Sclerosis","volume":"57","author":"Rajpurohit","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00018-022-04217-1","article-title":"Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes","volume":"79","author":"Rizzuti","year":"2022","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11940-023-00757-4","article-title":"Update on ALS Treatment","volume":"25","author":"Priyadarshini","year":"2023","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Dur\u00e3es, F., Pinto, M., and Sousa, E. (2018). Old Drugs as New Treatments for Neurodegenerative Diseases. Pharmaceuticals, 11.","DOI":"10.3390\/ph11020044"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/ijp.ijp_56_23","article-title":"Proteome architecture of human-induced pluripotent stem cell-derived three-dimensional organoids as a tool for early diagnosis of neuronal disorders","volume":"55","author":"Negi","year":"2023","journal-title":"Indian J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/17435390.2020.1759726","article-title":"A combined microRNA and proteome profiling to investigate the effect of ZnO nanoparticles on neuronal cells","volume":"14","author":"Srivastava","year":"2020","journal-title":"Nanotoxicology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1007\/s12035-024-03924-z","article-title":"Proteomic-miRNA Biomics Profile Reveals 2D Cultures of Human iPSC-Derived Neural Progenitor Cells More Sensitive than 3D Spheroid System Against the Experimental Exposure to Arsenic","volume":"61","author":"Negi","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Smith, A.S.T., Chun, C., Hesson, J., Mathieu, J., Valdmanis, P.N., Mack, D.L., Choi, B.O., Kim, D.H., and Bothwell, M. (2021). Human Induced Pluripotent Stem Cell-Derived TDP-43 Mutant Neurons Exhibit Consistent Functional Phenotypes Across Multiple Gene Edited Lines Despite Transcriptomic and Splicing Discrepancies. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.728707"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., and Patel, B.K. (2019). Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnmol.2019.00025"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.celrep.2015.04.007","article-title":"Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus","volume":"11","author":"Merkle","year":"2015","journal-title":"Cell Rep."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Feneberg, E., Gordon, D., Thompson, A.G., Finelli, M.J., Dafinca, R., Candalija, A., Charles, P.D., Mager, I., Wood, M.J., and Fischer, R. (2020). An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress. Neurobiol. Dis., 144.","DOI":"10.1016\/j.nbd.2020.105050"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1073\/pnas.1202922109","article-title":"Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability","volume":"109","author":"Bilican","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.neuron.2019.05.048","article-title":"Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS\/FTD","volume":"103","author":"Fang","year":"2019","journal-title":"Neuron"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4103\/1673-5374.330593","article-title":"Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"17","author":"Charif","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_25","first-page":"Cd011381","article-title":"Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: A network meta-analysis","volume":"1","author":"Ridley","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.yexcr.2013.05.025","article-title":"ALS\/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons","volume":"319","author":"Han","year":"2013","journal-title":"Exp. Cell Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wood, A., Gurfinkel, Y., Polain, N., Lamont, W., and Lyn Rea, S. (2021). Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094705"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bryce-Smith, S., Brown, A.L., Mehta, P.R., Mattedi, F., Mikheenko, A., Barattucci, S., Zanovello, M., Dattilo, D., Yome, M., and Hill, S.E. (2024). TDP-43 loss induces extensive cryptic polyadenylation in ALS\/FTD. bioRxiv.","DOI":"10.1101\/2024.01.22.576625"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1038\/ncomms7626","article-title":"Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells","volume":"6","author":"Du","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ding, Q., Chaplin, J., Morris, M.J., Hilliard, M.A., Wolvetang, E., Ng, D.C.H., and Noakes, P.G. (2021). TDP-43 Mutation Affects Stress Granule Dynamics in Differentiated NSC-34 Motoneuron-Like Cells. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.611601"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41594-020-00537-7","article-title":"TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS","volume":"28","author":"Zuo","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-020-00987-6","article-title":"Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function","volume":"8","author":"Briese","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jeon, Y.M., Kwon, Y., Lee, S., Kim, S., Jo, M., Lee, S., Kim, S.R., Kim, K., and Kim, H.J. (2021). Vitamin B12 Reduces TDP-43 Toxicity by Alleviating Oxidative Stress and Mitochondrial Dysfunction. Antioxidants, 11.","DOI":"10.3390\/antiox11010082"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s40478-022-01421-9","article-title":"Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: Evidence for multifaceted pathways underlying neurodegeneration","volume":"10","author":"Trist","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40035-022-00331-z","article-title":"TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis","volume":"11","author":"Durcan","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"de Mena, L., Lopez-Scarim, J., and Rincon-Limas, D.E. (2021). TDP-43 and ER Stress in Neurodegeneration: Friends or Foes?. Front. Mol. Neurosci., 14.","DOI":"10.3389\/fnmol.2021.772226"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.7150\/ijbs.12657","article-title":"Activation of ER Stress and Autophagy Induced by TDP-43 A315T as Pathogenic Mechanism and the Corresponding Histological Changes in Skin as Potential Biomarker for ALS with the Mutation","volume":"11","author":"Wang","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Houghton, O.H., Mizielinska, S., and Gomez-Suaga, P. (2022). The Interplay Between Autophagy and RNA Homeostasis: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.838402"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40035-020-00219-w","article-title":"Maintaining the balance of TDP-43, mitochondria, and autophagy: A promising therapeutic strategy for neurodegenerative diseases","volume":"9","author":"Huang","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Uechi, H., Sridharan, S., Nijssen, J., Bilstein, J., Iglesias-Artola, J.M., Kishigami, S., Casablancas-Antras, V., Poser, I., Martinez, E.J., and Boczek, E. (2019). Small molecule modulation of a redox-sensitive stress granule protein dissolves stress granules with beneficial outcomes for familial amyotrophic lateral sclerosis models. Cold Spring Harb. Lab., 721001.","DOI":"10.1101\/721001"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1523\/JNEUROSCI.3582-16.2017","article-title":"MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models","volume":"37","author":"Hoye","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"13318","DOI":"10.1073\/pnas.1008227107","article-title":"ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS\/TLS","volume":"107","author":"Ling","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Weng, Y.T., Chang, Y.M., and Chern, Y. (2023). The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043443"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/med.21364","article-title":"Mitoxantrone, More than Just Another Topoisomerase II Poison","volume":"36","author":"Evison","year":"2016","journal-title":"Med. Res. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1007\/s12035-023-03520-7","article-title":"Differential Expression of miRNAs in Amyotrophic Lateral Sclerosis Patients","volume":"60","author":"Gomes","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Brusati, A., Ratti, A., Pensato, V., Peverelli, S., Gentilini, D., Dalla Bella, E., Sorce, M.N., Meneri, M., Gagliardi, D., and Corti, S. (2022). Analysis of miRNA rare variants in amyotrophic lateral sclerosis and in silico prediction of their biological effects. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.1055313"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mcn.2015.12.008","article-title":"Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms","volume":"71","author":"Hur","year":"2016","journal-title":"Mol. Cell Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Rey, F., Maghraby, E., Messa, L., Esposito, L., Barzaghini, B., Pandini, C., Bordoni, M., Gagliardi, S., Diamanti, L., and Raimondi, M.T. (2023). Identification of a novel pathway in sporadic Amyotrophic Lateral Sclerosis mediated by the long non-coding RNA ZEB1-AS1. Neurobiol. Dis., 178.","DOI":"10.1016\/j.nbd.2023.106030"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jnnp-2020-324647","article-title":"Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis","volume":"92","author":"Kmetzsch","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41419-019-1859-8","article-title":"SIRT1-targeted miR-543 autophagy inhibition and epithelial-mesenchymal transition promotion in Helicobacter pylori CagA-associated gastric cancer","volume":"10","author":"Shi","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Chen, L., Sun, L., Dai, X., Li, T., Yan, X., Zhang, Y., Xiao, H., Shen, X., Huang, G., and Xiang, W. (2021). LncRNA CRNDE Promotes ATG4B-Mediated Autophagy and Alleviates the Sensitivity of Sorafenib in Hepatocellular Carcinoma Cells. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.687524"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.parkreldis.2016.09.028","article-title":"Parkinson\u2019s disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus","volume":"33","author":"Tatura","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"728","DOI":"10.4103\/1673-5374.322431","article-title":"MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches","volume":"17","author":"Martinez","year":"2022","journal-title":"Neural Regen. Res."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/4\/410\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:59:35Z","timestamp":1760029175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/4\/410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["pharmaceutics17040410"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17040410","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}